Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection
2021 Maggi, P; Ricci, E; Messina, V; Salzillo, A; Simeone, F; Iodice, A; DE SOCIO, G
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
2021 Guaraldi, G; Calza, S; Milic, J; Calcagno, A; Foca, E; Rota, M; Renzetti, S; Celotti, A; Siano, M; Celesia, Bm; Piconi, S; de Socio, G; Cattelan, Am; Orofino, G; Riva, A; Nozza, S; di Perri, G
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort
2021 Foca, E; Calcagno, A; Calza, S; Renzetti, S; Chiesa, A; Siano, M; De Socio, G; Piconi, S; Orofino, G; Madeddu, G; Cattelan, Am; Nozza, S; Ferrara, M; Milic, J; Celesia, Bm; Castelli, F; Guaraldi, G
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project
2008 Madeddu, G; Bonfanti, P; De Socio, G; Carradori, S; Grosso, C; Marconi, P; Penco, G; Rosella, E; Miccolis, S; Melzi, S; Mura, Ms; Landonio, S; Ricci, E; Quirino, T; Cisai, Group
HIV Infection - Screening, Diagnosis, and Treatment
2021 De Socio, G
Modelling the SARS-CoV-2 epidemic in Italy making use of the Istat seroprevalence survey
2021 Traini, Mc; Caponi, C; Ferrari, R; De Socio, G
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy.
2019 Castagna, A; Rusconi, S; Gulminetti, R; Bonora, S; Mazzola, G; Quiros-Roldan, Me; De Socio, G; Ladisa, N; Carosella, S; Cattelan, A; Di Giambenedetto, S; Mena, M; Poli, A; Galli, L; Riva, A; DAU Study, Group.
Comments on "Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C"
2022 Nicolini, La; Menzaghi, B; Molteni, C; Vichi, F; Cascio, A; Parisini, A; De Socio, G; Falasca, K; Bonfanti, P; Di Biagio, A
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
2022 Maggi, P; De Socio, G; Menzaghi, B; Molteni, C; Squillace, N; Taramasso, L; Guastavigna, M; Gamboni, G; Madeddu, G; Vichi, F; Cascio, A; Sarchi, E; Pellicano, G; Martinelli, Cv; Celesia, Bm; Valsecchi, L; Gulminetti, R; Cenderello, G; Parisini, A; Calza, L; Falasca, K; Orofino, G; Ricci, E; Di Biagio, A; Bonfanti, P
Reversibility of Central Nervous System Adverse Events in Course of Art
2022 Taramasso, L; Orofino, G; Ricci, E; Menzaghi, B; De Socio, G; Squillace, N; Madeddu, G; Vichi, F; Celesia, Bm; Molteni, C; Conti, F; Del Puente, F; Sarchi, E; Angioni, G; Cascio, A; Grosso, C; Parruti, G; Di Biagio, A; Bonfanti, P
Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort
2016 Capetti, Af; Sterrantino, G; Cossu, Mv; Orofino, G; Barbarini, G; De Socio, G; Di Giambenedetto, S; Di Biagio, A; Celesia, Bm; Argenteri, B; Rizzardini, G.
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
2020 Squillace, N; Ricci, E; Menzaghi, B; De Socio, G; Passerini, S; Martinelli, C; Mameli, Ms; Maggi, P; Falasca, K; Cordier, L; Celesia, Bm; Salomoni, E; Di Biagio, A; Pellicanò, Gf; Bonfanti, P; CISAI Study, Group.
The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study
2012 Bonfanti, P; De Socio, G; Ricci, E; Antinori, A; Martinelli, C; Vichi, F; Penco, G; Madeddu, G; Orofino, G; Valsecchi, L; Rusconi, S; Menzaghi, B; Pocaterra, D; Quirino, T.
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients
2013 Di Biagio, A; Ricci, E; Viscoli, C; Mesini, A; Menzaghi, B; Carenzi, L; Orofino, G; Parruti, G; Martinelli, C; Madeddu, G; De Socio, G; Franzetti, M; Quirino, T; Bonfanti, P; Cisai, Group
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study
2022 Taramasso, L; Falletta, A; Ricci, E; Orofino, G; Squillace, N; Menzaghi, B; De Socio, G; Molteni, C; Pellicanò, Gf; Gulminetti, R; Madeddu, G; Sarchi, E; Vichi, F; Celesia, Bm; Bonfanti, P; Di Biagio, A
Two-drug regimens with dolutegravir for maintaining viral suppression: looking at the right companion
2019 Castagna, A; Ladisa, N; Roldan, Meq; Ferraresi, A; Mena, M; Rusconi, S; Riva, A; Atzori, C; Frigerio, M; Falvella, Fs; Cattaneo, D; Spagnuolo, V; Poli, A; Galli, L; Castagna, A; Cattelan, Am; Cavinato, S; Mazzola, G; Cascio, A; Gulminetti, R; Pagnucco, L; De Socio, G; Di Giambenedetto, S; Ciccullo, A; Bonora, S; Ferrara, M; Carosella, S
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience
2019 Vitiello, P; Taramasso, L; Ricci, E; Maggi, P; Martinelli, C; Gabrielli, C; De Socio, G; Di Cristo, V; Rusconi, S; Falasca, K; Menzaghi, B; Tebini, A; Di Biagio, A
Waist circumference and body mass index in HIV infection
2011 De Socio, G; Ricci, E; Bonfanti, P; Quirino, T; Schillaci, G.
Weight Gain: A Possible Side Effect of All Antiretrovirals
2017 Taramasso, L; Ricci, E; Menzaghi, B; Orofino, G; Passerini, S; Madeddu, G; Martinelli, Cv; De Socio, G; Squillace, N; Rusconi, S; Bonfanti, P; Di Biagio, A
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years
2018 Guaraldi, G; Malagoli, A; Calcagno, A; Mussi, C; Celesia, Bm; Carli, F; Piconi, S; De Socio, G; Cattelan, Am; Orofino, G; Riva, A; Focà, E; Nozza, S; Di Perri, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection | 2021 | Maggi, P; Ricci, E; Messina, V; Salzillo, A; Simeone, F; Iodice, A; DE SOCIO, G | |
| Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV | 2021 | Guaraldi, G; Calza, S; Milic, J; Calcagno, A; Foca, E; Rota, M; Renzetti, S; Celotti, A; Siano, M; Celesia, Bm; Piconi, S; de Socio, G; Cattelan, Am; Orofino, G; Riva, A; Nozza, S; di Perri, G | |
| Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort | 2021 | Foca, E; Calcagno, A; Calza, S; Renzetti, S; Chiesa, A; Siano, M; De Socio, G; Piconi, S; Orofino, G; Madeddu, G; Cattelan, Am; Nozza, S; Ferrara, M; Milic, J; Celesia, Bm; Castelli, F; Guaraldi, G | |
| Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project | 2008 | Madeddu, G; Bonfanti, P; De Socio, G; Carradori, S; Grosso, C; Marconi, P; Penco, G; Rosella, E; Miccolis, S; Melzi, S; Mura, Ms; Landonio, S; Ricci, E; Quirino, T; Cisai, Group | |
| HIV Infection - Screening, Diagnosis, and Treatment | 2021 | De Socio, G | |
| Modelling the SARS-CoV-2 epidemic in Italy making use of the Istat seroprevalence survey | 2021 | Traini, Mc; Caponi, C; Ferrari, R; De Socio, G | |
| Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy. | 2019 | Castagna, A; Rusconi, S; Gulminetti, R; Bonora, S; Mazzola, G; Quiros-Roldan, Me; De Socio, G; Ladisa, N; Carosella, S; Cattelan, A; Di Giambenedetto, S; Mena, M; Poli, A; Galli, L; Riva, A; DAU Study, Group. | |
| Comments on "Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C" | 2022 | Nicolini, La; Menzaghi, B; Molteni, C; Vichi, F; Cascio, A; Parisini, A; De Socio, G; Falasca, K; Bonfanti, P; Di Biagio, A | |
| Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? | 2022 | Maggi, P; De Socio, G; Menzaghi, B; Molteni, C; Squillace, N; Taramasso, L; Guastavigna, M; Gamboni, G; Madeddu, G; Vichi, F; Cascio, A; Sarchi, E; Pellicano, G; Martinelli, Cv; Celesia, Bm; Valsecchi, L; Gulminetti, R; Cenderello, G; Parisini, A; Calza, L; Falasca, K; Orofino, G; Ricci, E; Di Biagio, A; Bonfanti, P | |
| Reversibility of Central Nervous System Adverse Events in Course of Art | 2022 | Taramasso, L; Orofino, G; Ricci, E; Menzaghi, B; De Socio, G; Squillace, N; Madeddu, G; Vichi, F; Celesia, Bm; Molteni, C; Conti, F; Del Puente, F; Sarchi, E; Angioni, G; Cascio, A; Grosso, C; Parruti, G; Di Biagio, A; Bonfanti, P | |
| Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort | 2016 | Capetti, Af; Sterrantino, G; Cossu, Mv; Orofino, G; Barbarini, G; De Socio, G; Di Giambenedetto, S; Di Biagio, A; Celesia, Bm; Argenteri, B; Rizzardini, G. | |
| The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile | 2020 | Squillace, N; Ricci, E; Menzaghi, B; De Socio, G; Passerini, S; Martinelli, C; Mameli, Ms; Maggi, P; Falasca, K; Cordier, L; Celesia, Bm; Salomoni, E; Di Biagio, A; Pellicanò, Gf; Bonfanti, P; CISAI Study, Group. | |
| The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study | 2012 | Bonfanti, P; De Socio, G; Ricci, E; Antinori, A; Martinelli, C; Vichi, F; Penco, G; Madeddu, G; Orofino, G; Valsecchi, L; Rusconi, S; Menzaghi, B; Pocaterra, D; Quirino, T. | |
| The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients | 2013 | Di Biagio, A; Ricci, E; Viscoli, C; Mesini, A; Menzaghi, B; Carenzi, L; Orofino, G; Parruti, G; Martinelli, C; Madeddu, G; De Socio, G; Franzetti, M; Quirino, T; Bonfanti, P; Cisai, Group | |
| Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study | 2022 | Taramasso, L; Falletta, A; Ricci, E; Orofino, G; Squillace, N; Menzaghi, B; De Socio, G; Molteni, C; Pellicanò, Gf; Gulminetti, R; Madeddu, G; Sarchi, E; Vichi, F; Celesia, Bm; Bonfanti, P; Di Biagio, A | |
| Two-drug regimens with dolutegravir for maintaining viral suppression: looking at the right companion | 2019 | Castagna, A; Ladisa, N; Roldan, Meq; Ferraresi, A; Mena, M; Rusconi, S; Riva, A; Atzori, C; Frigerio, M; Falvella, Fs; Cattaneo, D; Spagnuolo, V; Poli, A; Galli, L; Castagna, A; Cattelan, Am; Cavinato, S; Mazzola, G; Cascio, A; Gulminetti, R; Pagnucco, L; De Socio, G; Di Giambenedetto, S; Ciccullo, A; Bonora, S; Ferrara, M; Carosella, S | |
| Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience | 2019 | Vitiello, P; Taramasso, L; Ricci, E; Maggi, P; Martinelli, C; Gabrielli, C; De Socio, G; Di Cristo, V; Rusconi, S; Falasca, K; Menzaghi, B; Tebini, A; Di Biagio, A | |
| Waist circumference and body mass index in HIV infection | 2011 | De Socio, G; Ricci, E; Bonfanti, P; Quirino, T; Schillaci, G. | |
| Weight Gain: A Possible Side Effect of All Antiretrovirals | 2017 | Taramasso, L; Ricci, E; Menzaghi, B; Orofino, G; Passerini, S; Madeddu, G; Martinelli, Cv; De Socio, G; Squillace, N; Rusconi, S; Bonfanti, P; Di Biagio, A | |
| The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years | 2018 | Guaraldi, G; Malagoli, A; Calcagno, A; Mussi, C; Celesia, Bm; Carli, F; Piconi, S; De Socio, G; Cattelan, Am; Orofino, G; Riva, A; Focà, E; Nozza, S; Di Perri, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista69176
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa72
- 2020 - 202615564
- 2010 - 201926165
- 2000 - 200915952
- 1990 - 19997577
- 1980 - 19893194
- 1970 - 1979647
- 1968 - 19696
Editore
- Elsevier BV:PO Box 211, 1000 AE A...209
- Elsevier Science Limited:Oxford F...102
- American Institute of Physics:2 H...68
- Il Sole 24 Ore Edagricole:via Goi...67
- Springer Verlag Germany:Tiergarte...54
- American Chemical Society:1155 Si...52
- Annali Della Facolta di Agraria:U...44
- Royal Society of Chemistry:Thomas...41
- John Wiley & Sons Incorporated:Cu...40
- Giuffre Editore Spa:via Busto Ars...37
Rivista
- PHYSICS LETTERS. SECTION B828
- PHYSICAL REVIEW D, PARTICLES, FIE...675
- PHYSICAL REVIEW LETTERS651
- JOURNAL OF HIGH ENERGY PHYSICS530
- PHYSICAL REVIEW D361
- THE JOURNAL OF CHEMICAL PHYSICS290
- PLOS ONE286
- BLOOD273
- THE EUROPEAN PHYSICAL JOURNAL. C,...268
- NUCLEAR INSTRUMENTS & METHODS IN ...261
Serie
- STUDI E INTERVENTI1
Keyword
- Humans2084
- Female1055
- Male976
- Aged629
- Italy623
- Middle Aged602
- Adult532
- Animals396
- COVID-19374
- 80 and over269
Lingua
- eng51182
- ita13305
- fre260
- spa214
- lat88
- por85
- ger64
- und60
- enm53
- rus26
Accesso al fulltext
- no fulltext67643
- open1509
- reserved23
- partially open1
- restricted1